v3.21.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2020
Dec. 31, 2019
Current assets:    
Cash and cash equivalents $ 17,564 $ 5,789
Restricted cash 312 312
Accounts receivable, less allowance of $4,017 and $2,531 in 2020 and 2019, respectively 3,059 8,760
Inventory 11,157 10,995
Prepaid expenses and other current assets 3,018 1,163
Total current assets 35,110 27,019
Property, plant, and equipment, net 782 1,193
Goodwill 2,926 2,926
Right of use asset 1,976 276
Other assets 231 433
Total assets 41,025 31,847
Current liabilities:    
Accounts payable 2,651 5,332
Accrued liabilities 6,667 4,744
Deferred revenue, current portion 1,905 2,237
Term loan, net of discount   13,466
Total current liabilities 11,223 25,779
Deferred revenue 374 358
Warranty accrual 384 245
Non current term loans, net of discount 16,186  
Non current operating lease liability 1,774 4
Other liabilities 1,056 1,119
Total liabilities 30,997 27,505
Commitments and contingencies —Note 7
Redeemable preferred stock:    
Series E Preferred stock, par value $0.001 per share; 1,000 shares authorized, 0 and 70 shares issued and outstanding as of December 31, 2020 and 2019, respectively   3,965
Stockholders' equity:    
Series F Preferred stock, par value $0.001 per share; 18 shares authorized, 1 and 0 shares issued and outstanding as of December 31, 2020 and 2019, respectively 118  
Common stock, par value $0.001 per share; 180,000 and 40,000 shares authorized, 97,709 and 31,439 shares issued and 97,663 and 31,439 outstanding as of December 31, 2020 and 2019, respectively 98 31
Additional paid-in capital 261,573 235,594
Accumulated other comprehensive loss (385) (701)
Accumulated deficit (251,376) (234,547)
Total stockholders' equity 10,028 377
Total liabilities, redeemable preferred stock and stockholders' equity $ 41,025 $ 31,847

Source